Home › Funds › ALETHEA CAPITAL MANAGEMENT, LLC › KURA

ALETHEA CAPITAL MANAGEMENT, LLC position in KURA

KURA ONCOLOGY INC · Health Care

ALETHEA CAPITAL MANAGEMENT, LLC reported holding 2,175,838 shares of KURA (KURA ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$23.3M, representing 11.86% of its reported portfolio and ranking #3 among its reported holdings. ALETHEA CAPITAL MANAGEMENT, LLC has disclosed KURA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.18M sh
Reported value held$23.30M
Portfolio Weight11.86%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ALETHEA CAPITAL MANAGEMENT, LLC's KURA position evolved

ALETHEA CAPITAL MANAGEMENT, LLC first disclosed a stake in KURA in Q3 2023 at 350,445 shares (US$3.2M). The position peaked in Q2 2026 at 2,167,938 shares, worth US$23.8M. Across 13 filings, ALETHEA CAPITAL MANAGEMENT, LLC increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,175,838 shares valued at US$23.3M. Notable position changes include a 108% increase in Q3 2024 (shares fell 55% over the following quarter), a 84% trim in Q3 2025 (shares rose 17% over the following quarter), a 848% increase in Q4 2025 (shares fell 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 350.44K $3.20M New
Q4 2023 350.44K $5.04M Hold
Q1 2024 259.61K $5.54M Reduce
Q2 2024 265.91K $5.48M Add
Q3 2024 553.54K $10.82M Add
Q4 2024 558.44K $4.86M Add
Q1 2025 659.18K $4.35M Add
Q2 2025 949.28K $5.48M Add
Q3 2025 150.00K $277.50K Reduce
Q4 2025 1.42M $14.78M Add
Q1 2026 1.53M $12.43M Add
Q2 2026 2.17M $23.78M Add
Q3 2026 2.18M $23.30M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KURA and 13F data

KURA (KURA ONCOLOGY INC) is a Health Care company. 26 other funds we track also report a position in KURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$94.1M), BVF INC/IL (US$92.7M), ARMISTICE CAPITAL, LLC (US$40.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KURA

All KURA fund holders →

FAQ

How long has ALETHEA CAPITAL MANAGEMENT, LLC held KURA?

ALETHEA CAPITAL MANAGEMENT, LLC has disclosed KURA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ALETHEA CAPITAL MANAGEMENT, LLC's current position in KURA?

As of Q3 2026, ALETHEA CAPITAL MANAGEMENT, LLC holds 2.18M shares of KURA (KURA ONCOLOGY INC), valued at $23.30M, representing 11.86% of its reported portfolio and ranking #3.

Has ALETHEA CAPITAL MANAGEMENT, LLC been buying or selling KURA?

In the latest 13F filing (Q3 2026), ALETHEA CAPITAL MANAGEMENT, LLC held unchanged its position in KURA. The position peaked in Q2 2026 at 2.17M shares.

Which other funds hold KURA?

Other major institutional holders of KURA include MONTANOVA CAPITAL, LLC, BVF INC/IL, ARMISTICE CAPITAL, LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.